Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Minerva Surgical, Inc.
  6. News
  7. Summary
    UTRS   US60343F1066

MINERVA SURGICAL, INC.

(UTRS)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
2.140 USD   -2.73%
08/12Hologic Says US Appeals Court Affirms 2018 Patent Infringement Ruling
MT
08/10JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight
MT
08/10Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Earnings Flash (UTRS) MINERVA SURGICAL Reports Q1 Revenue $10.9M, vs. Street Est of $10.8M

05/11/2022 | 04:04pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
MINERVA S.A. 2.18% 14.07 Delayed Quote.32.74%
MINERVA SURGICAL, INC. -2.73% 2.14 Delayed Quote.-58.37%
All news about MINERVA SURGICAL, INC.
08/12Hologic Says US Appeals Court Affirms 2018 Patent Infringement Ruling
MT
08/10JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight
MT
08/10Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overwei..
MT
08/09MINERVA SURGICAL : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
PU
08/09MINERVA SURGICAL INC Management's Discussion and Analysis of Financial Condition and R..
AQ
08/09Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months E..
CI
08/09TRANSCRIPT : Minerva Surgical, Inc., Q2 2022 Earnings Call, Aug 09, 2022
CI
08/09MINERVA SURGICAL : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/09Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13M, vs. Street Est of $13.4M
MT
08/09Minerva Surgical Reports Second Quarter 2022 Financial Results
AQ
More news
Analyst Recommendations on MINERVA SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2022 51,1 M - -
Net income 2022 -32,6 M - -
Net Debt 2022 12,1 M - -
P/E ratio 2022 -1,88x
Yield 2022 -
Capitalization 61,8 M 61,8 M -
EV / Sales 2022 1,45x
EV / Sales 2023 1,88x
Nbr of Employees 157
Free-Float 92,6%
Chart MINERVA SURGICAL, INC.
Duration : Period :
Minerva Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MINERVA SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 2,14 $
Average target price 5,00 $
Spread / Average Target 134%
EPS Revisions
Managers and Directors
David M. Clapper President, Chief Executive Officer & Director
Joel R. Jung Chief Financial Officer
Ross A. Jaffe Chairman
Eugene V. Skalnyi Vice President-Medical Affairs
Dominique J. Filloux Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MINERVA SURGICAL, INC.-58.37%62
STRYKER CORPORATION-16.57%84 411
SMITH & NEPHEW PLC-18.52%11 104
INSPIRE MEDICAL SYSTEMS, INC.-4.39%6 300
AXONICS, INC.29.25%3 556
GLAUKOS CORPORATION13.37%2 397